Company Overview of Merck Serono S.A.
Merck Serono S.A., a biopharmaceutical company, discovers, develops, manufactures, and commercializes prescription medicines of chemical and biological origin in specialist indications. It develops drugs for neurodegenerative diseases, such as Rebif, a disease modifying drug to treat relapsing forms of multiple sclerosis; and Erbitux, an IgG1 monoclonal antibody targeting the epidermal growth factor receptor for treating squamous cell carcinoma of the head and neck, and metastatic colorectal cancer. The company also develops fertility drugs for various stages of the reproductive cycle and recombinant versions of various hormones needed to treat infertility, such as GONAL-f, a recombinant hum...
Frankfurter Strasse 250
Founded in 1987
Key Executives for Merck Serono S.A.
Chief Executive Officer and President
Head of Global Business Unit Allergy and Chief Executive Officer of Allergopharma
Chief Executive Officer of Consumer Health and President of Consumer Health
Head of Legal and Senior Vice President
Head of Global Business Development and Executive Vice President of Global Business Development & Strategy
Compensation as of Fiscal Year 2014.
Merck Serono S.A. Key Developments
Merck Serono Reports Revenue Results for the Year 2014
Mar 3 15
Merck Serono reported revenue results for the year 2014. For the year, the company's revenue declined by 1.4% year on year to EUR 5.975 billion, although its sales were up by 1.7% year on year.
Merck Serono Pharmaceuticals Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 08:55 AM
Feb 22 15
Merck Serono Pharmaceuticals Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 08:55 AM. Venue: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St, 40th Floor (D Elevator Bank), New York, NY10007, United States. Speakers: Catherine Pickering, Head of Oncology Licensing, Global BD.
Merck Serono S.A. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 08:00 AM
Dec 17 14
Merck Serono S.A. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 08:00 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States. Speakers: Catherine-Anne Pickering, Head, Oncology Licensing and Global Business Development.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|